What is better Zappyhire or IBM Kenexa? With a wide range of functions, pricing, terms, and more to check, choosing the right Applicant Tracking Systems for your company is tricky. However by working with our system, you can easily match the characteristics of Zappyhire and IBM Kenexa as well as their general score, respectively as: 8.0 and 8.8 for overall score and 97% and 100% for user satisfaction.
You can also compare them feature by feature and see which program is a more suitable fit for your enterprise. Keep in mind to use a free trial first before opting in for a plan to experience how the program works in real scenarios.
As of now, the top products in our HR Management Software category are: Zoho People, BambooHR, Gusto HR.
While Zappyhire SMB and enterprise pricing starts at $39/month, the specific details are available only upon request. Contact the vendor for more information and book a free demo.
All the data, facts and experiences that we presented in this table were collected from official vendor pages, promotional materials available online, actual experience from real users as well as our personal direct use of every product by an expert. We put a lot of effort to comprehensively examine each app, therefore we not only examine it ourselves, but we also match our observations with views of other members from the SaaS community.
Page last modified
Why is FinancesOnline free?
FinancesOnline is available for free for all business professionals interested in an efficient way to find top-notch SaaS solutions. We are able to keep our service free of charge thanks to cooperation with some of the vendors, who are willing to pay us for traffic and sales opportunities provided by our website. Please note, that FinancesOnline lists all vendors, we’re not limited only to the ones that pay us, and all software providers have an equal opportunity to get featured in our rankings and comparisons, win awards, gather user reviews, all in our effort to give you reliable advice that will enable you to make well-informed purchase decisions.
